[1] Harada H, Kitazaki K, Tsujino T, et al. Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats[J]. Hypertens Res,2000, 23(3): 277-284. [2] Nakagawa M, Takeda K, Yoshitomi T, et al. Antihypertensive effect of taurine on salt-induced hypertension[J]. Adv Exp Med Biol, 1994, 359: 197-206. [3] Abebe W, Mozaffari MS. Effects of chronic taurine treatment on reactivity of the rat aorta[J]. Amino Acids, 2000, 19(3/4): 615-623. [4] Niu LG, Zhang MS, Liu Y, et al. Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries[J]. Eur J Pharmacol, 2008, 580(1/2): 169-174. [5] Harada H, Tsujino T, Watari Y, et al. Oral taurine supplementation prevents fructose-induced hypertension in rats[J]. Heart Vessels, 2004, 19(3): 132-136. [6] Zhang M, Bi LF, Fang JH, et al. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects[J]. Amino Acids, 2004, 26(3): 267-271. [7] 李洁, 薛文鑫, 牛龙刚, 等. 高果糖诱导大鼠胰岛素敏感性及血压改变[J]. 山西医科大学学报,2007, 38(9): 786-788. [8] 王丹, 张轩萍, 董秋菊, 等. 依那普利对大鼠离体胸主动脉的舒张作用及其机制[J]. 中国临床药理学与治疗学, 2008, 13(2): 149-153. [9] Bortolotto LA. Modifications of structural and functional properties of large arteries in diabetes mellitus[J]. Arq Bras Endocrinol Metabol, 2007, 51(2): 176-184. [10]Di Leo MA, Santini SA, Silveri NG, et al. Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats[J]. Amino Acids, 2004, 27(2): 187-191. [11]Song XD, Chen CZ, Dong B, et al. Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts[J]. Zhonghua Yan Ke Za Zhi,2003, 39(10): 605-609. [12]李杰. 心血管压力反射敏感性与高血压[J]. 中国临床药理学与治疗学, 2001, 6(03): 284-286. [13]罗助荣, 陈孟扬. 高血压患者压力反射敏感性与部分内分泌激素的相关性研究[J]. 临床心血管病杂志,1998, 14(6): 347-350. |